Rochester, NY (PRWEB) April 05, 2014
Hepatitis B (HBV) can damage the brain of infected babies (1). The virus cause brachial plexus injury (injury to the network of nerves that conducts signals from the spinal cord), cephalhematoma (bleeding between the membranes that cover the bones of the skull), foetal distress, feeding difficulties, intraventricular haemorrhage (bleeding into the brain’s structures that hold cerebro-spinal fluid), and neonatal seizures (1). polyDNA therefore recommends that women planning a pregnancy get tested for HBV. If positive, they should then ask their doctors about Gene-Eden-VIR. This natural product was clinically proven to reduce symptoms of HBV infection in a study that followed FDA guidelines.
The most common source of infection is the mother. Researchers found that “The risk of an adverse neurological outcome was higher in infants born to mothers with hepatitis viral infection (7.2% for HCV, 5.0% for HBV), compared with infants of hepatitis virus-free mothers (4.2%). After adjusting for potential confounders, women with HBV were twice as likely to have infants who suffered from brachial plexus injury (1).”
“All pregnant women should be tested for hepatitis B! Testing is especially important for women who fall into high-risk groups such as health care workers, women from ethnic communities where hepatitis B is common, spouses or partners living with an infected person, etc. If you are pregnant, be sure your doctor tests you for hepatitis B before your baby is born.” (See the Hepatitis B Foundation, last modified October 17, 2012) (2).
It is very important to be tested since “the virus can be passed on to your newborn baby during delivery. If your doctor is aware that you have hepatitis B, he or she can make arrangements to have the proper medications in the delivery room to prevent your baby from being infected. If the proper procedures are not followed, your baby has a 95% chance of developing chronic hepatitis B! (2)”
“We recommend that when planning a pregnancy, a woman should get tested for HBV. If positive, she should ask the doctor about Gene-Eden-VIR. However, before conceiving, she should stop taking Gene-Eden-VIR, and then start taking it again after delivery.” - Mike Evans, polyDNA
A study published on August 12, 2013 in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs, showed that Gene-Eden-VIR reduced HBV symptoms. Study authors wrote that, “Individuals infected with the hepatitis virus… reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR (3).” The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms (3).”
Research shows that an infection with hepatitis B also causes a feeling of physical and mental fatigue. Since Gene-Eden-VIR is antiviral, a second post-marketing clinical study showed that Gene-Eden-VIR decreases the feeling of physical and mental fatigue. That study was published in March, 2014 in the journal Pharmacology & Pharmacy (4).
To read the study on the antiviral nature of Gene-Eden-VIR, visit:http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.UzPvtaiSz90.
To read the study on Gene-Eden-VIR’s effects on reducing physical and mental fatigue, visit:http://www.scirp.org/journal/PaperInformation.aspx?PaperID=44234#.UzPwAqiSz90.
To learn more about Gene-Eden-VIR, and the hepatitis B virus, visit http://gene-eden-kill-virus.com/hepatitis-B-Virus.php. All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
(1) Maternal hepatitis B and hepatitis C infection and neonatal neurological outcomes. Published on March 26, 2014.
(2) Hepatitis B Foundation - Pregnancy and HBV: FAQ. Last modified October 17, 2012.
(3) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.
(4) Gene-Eden-VIR Decreased Physical and Mental Fatigue in a Post Marketing Clinical Study That Followed FDA Guidelines; Results Support Microcompetition Theory. Published in March 2014.
polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.
In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.
polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.